Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.

28 August 2022 (08:30 - 08:45)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Elisa Avolio

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

CRISPR/Cas9 editing of CaMKII as a strategy for cardioprotection against ischemia/reperfusion injury.

Professor S. Lebek (Regensburg, DE)

Presentation thumbnail

Is empagliflozin still cardioprotective in SGLT2 KO mice?

Miss S. Chen (Amsterdam, NL)

Presentation thumbnail

Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.

Doctor A. Mroueh (Strasbourg, FR)

Access the full session

Session thumbnail

Basic and Translational Late-Breaking Science 1

The Event

Event poster

ESC Congress 2022

28 August 2022 08:30 CET

You may be interested in

Congress Presentation

Pathophysiology of myocardial and pericardial involvement in COVID-19

Congress Presentation

Macrophage-derived SPP1 exacerbate myocardial injury by interacting with fibroblasts in viral myocarditis

Congress Presentation

Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources